Aspirin dose and duration of use and risk of colorectal cancer in men.
about
Aspirin in the Chemoprevention of Colorectal Neoplasia: An OverviewAspirin, cyclooxygenase inhibition and colorectal cancerMolecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary fieldFinding Ponce de Leon's Pill: Challenges in Screening for Anti-Aging MoleculesBerberine Inhibits Invasion and Metastasis of Colorectal Cancer Cells via COX-2/PGE2 Mediated JAK2/STAT3 Signaling PathwayFour jointed box 1 promotes angiogenesis and is associated with poor patient survival in colorectal carcinomaCurrent Hypothesis for the Relationship between Dietary Rice Bran Intake, the Intestinal Microbiota and Colorectal Cancer PreventionCyclooxygenase-2 and cancer treatment: understanding the risk should be worth the rewardA prospective study of aspirin use and the risk of gastrointestinal bleeding in menThe Your Disease Risk Index for colorectal cancer is an inaccurate risk stratification tool for advanced colorectal neoplasia at screening colonoscopy.A simple algebraic cancer equation: calculating how cancers may arise with normal mutation rates.A combination of aspirin and gamma-tocopherol is superior to that of aspirin and alpha-tocopherol in anti-inflammatory action and attenuation of aspirin-induced adverse effects.Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD)Critical Overview on the Benefits and Harms of Aspirin.Aspirin use and survival after diagnosis of colorectal cancerNon-steroidal anti-inflammatory drug and aspirin use and the risk of head and neck cancer: a systematic review.Primary and secondary prevention of colorectal cancerCalcium prevents tumorigenesis in a mouse model of colorectal cancerDietary intake of fish, ω-3 and ω-6 fatty acids and risk of colorectal cancer: A prospective study in U.S. men and womenPrimary prevention of colorectal cancer.Meta-analyses of colorectal cancer risk factors.Measures of adiposity are associated with increased risk of peptic ulcer.Role of aspirin in cancer prevention.Aspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterationsConcept of chemoprevention in colorectal cancer.Estimates of benefits and harms of prophylactic use of aspirin in the general population.Dose-risk and duration-risk relationships between aspirin and colorectal cancer: a meta-analysis of published cohort studies.Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs.Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male miceNon-steroidal anti-inflammatory drugs use is associated with reduced risk of inflammation-associated cancers: NIH-AARP studyUse of aspirin or nonsteroidal anti-inflammatory drugs increases risk for diverticulitis and diverticular bleedingAspirin and familial adenomatous polyposis: coming full circlePharmacological and dietary prevention for colorectal cancer.The role of COX-2 in intestinal inflammation and colorectal cancerNon-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort.Association of Nonsteroidal Anti-Inflammatory Drugs with Colorectal Cancer by Subgroups in the VITamins and Lifestyle (VITAL) StudyStatin use and the risk of renal cell carcinoma in 2 prospective US cohortsMoving beyond diet and colorectal cancer.Aspirin use, body mass index, physical activity, plasma C-peptide, and colon cancer risk in US health professionals.Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths.
P2860
Q22306433-BD454DA2-EB76-45F0-A01F-89A712DECA17Q24598813-EA89AD54-CCF2-45E2-B922-96FD3BB1F514Q24620628-055AE23E-5A4B-469A-AF2A-EAA675C6F6B2Q26747742-AE5D0ED7-68AE-4033-815F-0A8C98C21380Q27309703-7A3BC180-354D-46C7-AA6A-ED84CED52E4CQ27310820-D558B303-B063-47BA-834F-8D4760159A09Q28080177-C151E08A-D825-4D69-8CA4-784420A7A0A8Q28274081-7D856536-7A74-4C1F-A9B9-AE5BB1A41538Q28743884-038E6B3E-D42E-474F-AD21-1CFE69E68608Q31064072-86573D84-12A8-42F2-ADDC-E0A2D9B06925Q33522055-9F7FE1CF-AB37-47AC-AD53-C6D7442D5586Q33561779-60AE89F9-7958-40F8-8109-D094AE55D6A0Q33648694-7A7D81D6-777E-4FBC-9B43-810122A5083CQ33664298-D55DA5CF-0C5A-4EE7-87F2-36D69F70025DQ33764480-CC9922A8-FE47-4E02-8E68-694AF08A9B71Q33848015-930BCE57-85C1-42BD-ABCD-711E0785A7DCQ33976246-7EE8CF4B-FA47-4D90-8780-38AB5B3F7039Q33998926-5008A62D-B3F8-4132-A10F-F43BC6653265Q34156633-F148E0F4-8B4B-40E7-82DD-A686F1848FF7Q34165145-95EEE471-64F7-468B-A6AB-7AC43122E82CQ34165563-8DA6C56E-10C3-4375-A0CF-0846C2267358Q34224965-26782831-76D5-4919-8E02-CB95CA7F203CQ34376832-70C8B61A-81B8-40F5-89D1-88BA0FC473F9Q34390505-3C3ADAD1-DD42-4422-A91D-D300A298BB9BQ34390842-479A0620-0085-45F2-B4F8-26593DA9EDCAQ34432503-0E0729DE-1F4E-4B37-BEFE-FD4F0F9C0282Q34603649-FEF26735-FBFE-4181-A6B8-287EC0100F6CQ34629246-283CFF22-6CF2-4435-BC27-D544059AD1ECQ34796688-EAB905CB-7119-4DF9-83E0-10B7C4EA9F83Q34797536-DA562056-11FF-4C4A-9046-1FA36AF17337Q34851812-550DCF48-6042-4C55-8773-702C2F598C43Q34992425-B58B8A68-7944-4352-A049-668568CB6BDBQ35051366-7902BA9E-59E1-4915-9BE9-D09F305B40D7Q35234704-7E818C25-FCCC-4DF6-929B-8099A1BC6130Q35244467-E79CE2B4-E885-4036-A61B-32A44D8178B0Q35251591-D66CCC59-16CD-4A2A-B969-635E3C369D66Q35354232-31514B6D-C4CA-4001-B8B0-298555E643ACQ35447411-55208926-233E-41ED-BD0E-2ECF9474D4C5Q35450708-8764B79C-6348-47AD-9FB4-C5D6DA3D62DFQ35878265-080DDA23-FA02-487B-A4EB-0ABAA1CE6DAB
P2860
Aspirin dose and duration of use and risk of colorectal cancer in men.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Aspirin dose and duration of use and risk of colorectal cancer in men.
@ast
Aspirin dose and duration of use and risk of colorectal cancer in men.
@en
Aspirin dose and duration of use and risk of colorectal cancer in men.
@nl
type
label
Aspirin dose and duration of use and risk of colorectal cancer in men.
@ast
Aspirin dose and duration of use and risk of colorectal cancer in men.
@en
Aspirin dose and duration of use and risk of colorectal cancer in men.
@nl
prefLabel
Aspirin dose and duration of use and risk of colorectal cancer in men.
@ast
Aspirin dose and duration of use and risk of colorectal cancer in men.
@en
Aspirin dose and duration of use and risk of colorectal cancer in men.
@nl
P2860
P50
P1433
P1476
Aspirin dose and duration of use and risk of colorectal cancer in men
@en
P2093
Andrew T Chan
P2860
P356
10.1053/J.GASTRO.2007.09.035
P407
P577
2007-09-26T00:00:00Z